Patent · US Active

Therapeutic dendrimers

US11717574B2 · kind B2 · utility

0Cited by
10References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 11, 2020
Grant dateAug 8, 2023
Priority date—
Expiry dateMay 28, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08G83/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are dendrimers of formula (I): and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising the dendrimer of formula (I) and methods of using the same for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.